Outcome of acute liver failure in the elderly

Frank V. Schiødt, Raymond T. Chung, Michael L. Schilsky, J. Eileen Hay, Erik Christensen, William M. Lee, George A. Ostapowicz, Julie Polson, Anne M. Larson, Timothy Davern, Timothy M McCashland, Natalie Murray, A. Obaid S Shaikh, Andres Blei, Atif Zaman, Steven H B Han, Robert Fontana, Brendan McGuire, Ray Chung, Alastair Smith & 10 others Robert Brown, Jeffrey Crippin, Edwin Harrison, Adrian Reuben, Santiago Munoz, Rajender Reddy, R. Todd Stravitz, Lorenzo Rossaro, Raj Satyanarayana, Tarek Hassanein

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Older age is considered a poor prognostic factor in acute liver failure (ALF) and may still be considered a relative contraindication for liver transplantation for ALF. We aimed to evaluate the impact of older age, defined as age ≥ 60 years, on outcomes in patients with ALF. One thousand one hundred twenty-six consecutive prospective patients from the US Acute Liver Failure Study Group registry were studied. The median age was 38 years (range, 15-81 years). One thousand sixteen patients (90.2%) were younger than 60 years (group 1), and 499 (49.1%) of these had acetaminophen-induced ALF; this rate of acetaminophen-induced ALF was significantly higher than that in patients ≥ 60 years (group 2; n = 110; 23.6% with acetaminophen-induced ALF, P < 0.001). The overall survival rate was 72.7% in group 1 and 60.0% in group 2 (not significant) for acetaminophen patients and 67.9% in group 1 and 48.2% in group 2 for non-acetaminophen patients (P < 0.001). The spontaneous survival rate (ie, survival without liver transplantation) was 64.9% in group 1 and 60.0% in group 2 (not significant) for acetaminophen patients and 30.8% in group 1 and 24.7% in group 2 for non-acetaminophen patients (P = 0.27). Age was not a significant predictor of spontaneous survival in multiple logistic regression analyses. Group 2 patients were listed for liver transplantation significantly less than group 1 patients. Age was listed as a contraindication for transplantation in 5 patients. In conclusion, in contrast to previous studies, we have demonstrated a relatively good spontaneous survival rate for older patients with ALF when it is corrected for etiology. However, overall survival was better for younger non-acetaminophen patients. Fewer older patients were listed for transplantation.

Original languageEnglish (US)
Pages (from-to)1481-1487
Number of pages7
JournalLiver Transplantation
Volume15
Issue number11
DOIs
StatePublished - Nov 1 2009

Fingerprint

Acute Liver Failure
Acetaminophen
Liver Transplantation
Survival Rate
Survival
Transplantation
Registries

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Cite this

Schiødt, F. V., Chung, R. T., Schilsky, M. L., Hay, J. E., Christensen, E., Lee, W. M., ... Hassanein, T. (2009). Outcome of acute liver failure in the elderly. Liver Transplantation, 15(11), 1481-1487. https://doi.org/10.1002/lt.21865

Outcome of acute liver failure in the elderly. / Schiødt, Frank V.; Chung, Raymond T.; Schilsky, Michael L.; Hay, J. Eileen; Christensen, Erik; Lee, William M.; Ostapowicz, George A.; Polson, Julie; Larson, Anne M.; Davern, Timothy; McCashland, Timothy M; Murray, Natalie; Shaikh, A. Obaid S; Blei, Andres; Zaman, Atif; Han, Steven H B; Fontana, Robert; McGuire, Brendan; Chung, Ray; Smith, Alastair; Brown, Robert; Crippin, Jeffrey; Harrison, Edwin; Reuben, Adrian; Munoz, Santiago; Reddy, Rajender; Stravitz, R. Todd; Rossaro, Lorenzo; Satyanarayana, Raj; Hassanein, Tarek.

In: Liver Transplantation, Vol. 15, No. 11, 01.11.2009, p. 1481-1487.

Research output: Contribution to journalArticle

Schiødt, FV, Chung, RT, Schilsky, ML, Hay, JE, Christensen, E, Lee, WM, Ostapowicz, GA, Polson, J, Larson, AM, Davern, T, McCashland, TM, Murray, N, Shaikh, AOS, Blei, A, Zaman, A, Han, SHB, Fontana, R, McGuire, B, Chung, R, Smith, A, Brown, R, Crippin, J, Harrison, E, Reuben, A, Munoz, S, Reddy, R, Stravitz, RT, Rossaro, L, Satyanarayana, R & Hassanein, T 2009, 'Outcome of acute liver failure in the elderly', Liver Transplantation, vol. 15, no. 11, pp. 1481-1487. https://doi.org/10.1002/lt.21865
Schiødt FV, Chung RT, Schilsky ML, Hay JE, Christensen E, Lee WM et al. Outcome of acute liver failure in the elderly. Liver Transplantation. 2009 Nov 1;15(11):1481-1487. https://doi.org/10.1002/lt.21865
Schiødt, Frank V. ; Chung, Raymond T. ; Schilsky, Michael L. ; Hay, J. Eileen ; Christensen, Erik ; Lee, William M. ; Ostapowicz, George A. ; Polson, Julie ; Larson, Anne M. ; Davern, Timothy ; McCashland, Timothy M ; Murray, Natalie ; Shaikh, A. Obaid S ; Blei, Andres ; Zaman, Atif ; Han, Steven H B ; Fontana, Robert ; McGuire, Brendan ; Chung, Ray ; Smith, Alastair ; Brown, Robert ; Crippin, Jeffrey ; Harrison, Edwin ; Reuben, Adrian ; Munoz, Santiago ; Reddy, Rajender ; Stravitz, R. Todd ; Rossaro, Lorenzo ; Satyanarayana, Raj ; Hassanein, Tarek. / Outcome of acute liver failure in the elderly. In: Liver Transplantation. 2009 ; Vol. 15, No. 11. pp. 1481-1487.
@article{863cfce460534cf58e8fd7caec4f6e93,
title = "Outcome of acute liver failure in the elderly",
abstract = "Older age is considered a poor prognostic factor in acute liver failure (ALF) and may still be considered a relative contraindication for liver transplantation for ALF. We aimed to evaluate the impact of older age, defined as age ≥ 60 years, on outcomes in patients with ALF. One thousand one hundred twenty-six consecutive prospective patients from the US Acute Liver Failure Study Group registry were studied. The median age was 38 years (range, 15-81 years). One thousand sixteen patients (90.2{\%}) were younger than 60 years (group 1), and 499 (49.1{\%}) of these had acetaminophen-induced ALF; this rate of acetaminophen-induced ALF was significantly higher than that in patients ≥ 60 years (group 2; n = 110; 23.6{\%} with acetaminophen-induced ALF, P < 0.001). The overall survival rate was 72.7{\%} in group 1 and 60.0{\%} in group 2 (not significant) for acetaminophen patients and 67.9{\%} in group 1 and 48.2{\%} in group 2 for non-acetaminophen patients (P < 0.001). The spontaneous survival rate (ie, survival without liver transplantation) was 64.9{\%} in group 1 and 60.0{\%} in group 2 (not significant) for acetaminophen patients and 30.8{\%} in group 1 and 24.7{\%} in group 2 for non-acetaminophen patients (P = 0.27). Age was not a significant predictor of spontaneous survival in multiple logistic regression analyses. Group 2 patients were listed for liver transplantation significantly less than group 1 patients. Age was listed as a contraindication for transplantation in 5 patients. In conclusion, in contrast to previous studies, we have demonstrated a relatively good spontaneous survival rate for older patients with ALF when it is corrected for etiology. However, overall survival was better for younger non-acetaminophen patients. Fewer older patients were listed for transplantation.",
author = "Schi{\o}dt, {Frank V.} and Chung, {Raymond T.} and Schilsky, {Michael L.} and Hay, {J. Eileen} and Erik Christensen and Lee, {William M.} and Ostapowicz, {George A.} and Julie Polson and Larson, {Anne M.} and Timothy Davern and McCashland, {Timothy M} and Natalie Murray and Shaikh, {A. Obaid S} and Andres Blei and Atif Zaman and Han, {Steven H B} and Robert Fontana and Brendan McGuire and Ray Chung and Alastair Smith and Robert Brown and Jeffrey Crippin and Edwin Harrison and Adrian Reuben and Santiago Munoz and Rajender Reddy and Stravitz, {R. Todd} and Lorenzo Rossaro and Raj Satyanarayana and Tarek Hassanein",
year = "2009",
month = "11",
day = "1",
doi = "10.1002/lt.21865",
language = "English (US)",
volume = "15",
pages = "1481--1487",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - Outcome of acute liver failure in the elderly

AU - Schiødt, Frank V.

AU - Chung, Raymond T.

AU - Schilsky, Michael L.

AU - Hay, J. Eileen

AU - Christensen, Erik

AU - Lee, William M.

AU - Ostapowicz, George A.

AU - Polson, Julie

AU - Larson, Anne M.

AU - Davern, Timothy

AU - McCashland, Timothy M

AU - Murray, Natalie

AU - Shaikh, A. Obaid S

AU - Blei, Andres

AU - Zaman, Atif

AU - Han, Steven H B

AU - Fontana, Robert

AU - McGuire, Brendan

AU - Chung, Ray

AU - Smith, Alastair

AU - Brown, Robert

AU - Crippin, Jeffrey

AU - Harrison, Edwin

AU - Reuben, Adrian

AU - Munoz, Santiago

AU - Reddy, Rajender

AU - Stravitz, R. Todd

AU - Rossaro, Lorenzo

AU - Satyanarayana, Raj

AU - Hassanein, Tarek

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Older age is considered a poor prognostic factor in acute liver failure (ALF) and may still be considered a relative contraindication for liver transplantation for ALF. We aimed to evaluate the impact of older age, defined as age ≥ 60 years, on outcomes in patients with ALF. One thousand one hundred twenty-six consecutive prospective patients from the US Acute Liver Failure Study Group registry were studied. The median age was 38 years (range, 15-81 years). One thousand sixteen patients (90.2%) were younger than 60 years (group 1), and 499 (49.1%) of these had acetaminophen-induced ALF; this rate of acetaminophen-induced ALF was significantly higher than that in patients ≥ 60 years (group 2; n = 110; 23.6% with acetaminophen-induced ALF, P < 0.001). The overall survival rate was 72.7% in group 1 and 60.0% in group 2 (not significant) for acetaminophen patients and 67.9% in group 1 and 48.2% in group 2 for non-acetaminophen patients (P < 0.001). The spontaneous survival rate (ie, survival without liver transplantation) was 64.9% in group 1 and 60.0% in group 2 (not significant) for acetaminophen patients and 30.8% in group 1 and 24.7% in group 2 for non-acetaminophen patients (P = 0.27). Age was not a significant predictor of spontaneous survival in multiple logistic regression analyses. Group 2 patients were listed for liver transplantation significantly less than group 1 patients. Age was listed as a contraindication for transplantation in 5 patients. In conclusion, in contrast to previous studies, we have demonstrated a relatively good spontaneous survival rate for older patients with ALF when it is corrected for etiology. However, overall survival was better for younger non-acetaminophen patients. Fewer older patients were listed for transplantation.

AB - Older age is considered a poor prognostic factor in acute liver failure (ALF) and may still be considered a relative contraindication for liver transplantation for ALF. We aimed to evaluate the impact of older age, defined as age ≥ 60 years, on outcomes in patients with ALF. One thousand one hundred twenty-six consecutive prospective patients from the US Acute Liver Failure Study Group registry were studied. The median age was 38 years (range, 15-81 years). One thousand sixteen patients (90.2%) were younger than 60 years (group 1), and 499 (49.1%) of these had acetaminophen-induced ALF; this rate of acetaminophen-induced ALF was significantly higher than that in patients ≥ 60 years (group 2; n = 110; 23.6% with acetaminophen-induced ALF, P < 0.001). The overall survival rate was 72.7% in group 1 and 60.0% in group 2 (not significant) for acetaminophen patients and 67.9% in group 1 and 48.2% in group 2 for non-acetaminophen patients (P < 0.001). The spontaneous survival rate (ie, survival without liver transplantation) was 64.9% in group 1 and 60.0% in group 2 (not significant) for acetaminophen patients and 30.8% in group 1 and 24.7% in group 2 for non-acetaminophen patients (P = 0.27). Age was not a significant predictor of spontaneous survival in multiple logistic regression analyses. Group 2 patients were listed for liver transplantation significantly less than group 1 patients. Age was listed as a contraindication for transplantation in 5 patients. In conclusion, in contrast to previous studies, we have demonstrated a relatively good spontaneous survival rate for older patients with ALF when it is corrected for etiology. However, overall survival was better for younger non-acetaminophen patients. Fewer older patients were listed for transplantation.

UR - http://www.scopus.com/inward/record.url?scp=72949088803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949088803&partnerID=8YFLogxK

U2 - 10.1002/lt.21865

DO - 10.1002/lt.21865

M3 - Article

VL - 15

SP - 1481

EP - 1487

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 11

ER -